Figure 5.
Overall survival rates for (a) patients with tumours harbouring APC/CTNNB1/ZNRF3 alterations in comparison to ones without, (b) overall survival remained significant after removal of patients under 15years of age at the time of operation. (c) Overall survival rates for patients with tumours harbouring CTNNB1 mutations and deletions in comparison to ones without, (d) overall survival in chart c remained significant after removal of patients under 15 years of age at the time of operation.